Sung Janice S, Dershaw D David
Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Magn Reson Imaging Clin N Am. 2013 Aug;21(3):509-17. doi: 10.1016/j.mric.2013.02.006. Epub 2013 Apr 10.
Mammography is the only imaging modality that has been validated by multiple randomized clinical trials and meta-analyses to reduce mortality from breast cancer. Although it is demonstrated to be effective in reducing mortality from breast cancer, mammography has its limitations, especially in young high-risk women with dense breasts. Other imaging modalities have been pursued as an adjunct screening modality in this population. Of these, the most widely accepted is contrast-enhanced breast magnetic resonance (MR) imaging. This article reviews current recommendations and limitations of using MR imaging of the breast to screen asymptomatic women at high risk for breast cancer.
乳腺钼靶摄影是唯一经过多项随机临床试验和荟萃分析验证可降低乳腺癌死亡率的影像学检查方法。尽管乳腺钼靶摄影已被证明在降低乳腺癌死亡率方面有效，但它也有其局限性，尤其是在乳房致密的年轻高危女性中。其他影像学检查方法已被用作该人群的辅助筛查手段。其中，最广泛接受的是对比增强乳腺磁共振（MR）成像。本文综述了使用乳腺MR成像对无症状乳腺癌高危女性进行筛查的当前建议和局限性。
